Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the "Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions".
<h4>Objective</h4>Chagas disease (CD) globalization facilitated the co-infection with Human Immunodeficiency Virus (HIV) in endemic and non-endemic areas. Considering the underestimation of Trypanosoma cruzi (T. cruzi)-HIV co-infection and the risk of life-threatening Chagas Disease Reac...
Saved in:
Similar Items
-
Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection.
by: Vera Lúcia Teixeira de Freitas, et al.
Published: (2024) -
Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection
by: Vera Lúcia Teixeira de Freitas, et al.
Published: (2024) -
Correction: Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the "Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions"
Published: (2023) -
Biology of Trypanosoma cruzi: An update Biología del Trypanosoma cruzi: Actualización
by: André Vianna Martins, et al.
Published: (2012) -
Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients.
by: Yagahira E Castro-Sesquen, et al.
Published: (2016)